Connective Tissue Growth Factor and Cardiac Fibrosis after Myocardial Infarction

Journal of Histochemistry and Cytochemistry - Tập 53 Số 10 - Trang 1245-1256 - 2005
Rachael Dean1, Leanne C. Balding1, Riccardo Candido1, Wendy C. Burns2, Zemin Cao1, Stephen M. Twigg3, Louise M. Burrell1
1Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia (RGD,LCB,RC,ZC,LMB)
2Diabetic Complications Group, Baker Heart Research Institute, Prahan, Victoria, Australia (WCB)
3Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St. Leonards, New South Wales, Australia (SMT)

Tóm tắt

The temporal and spatial expression of transforming growth factor (TGF)-β1 and connective tissue growth factor (CTGF) was assessed in the left ventricle of a myocardial infarction (MI) model of injury with and without angiotensin-converting enzyme (ACE) inhibition. Coronary artery ligated rats were killed 1, 3, 7, 28, and 180 days after MI. TGF-β1, CTGF, and procollagen α1(I) mRNA were localized by in situ hybridization, and TGF-β1 and CTGF protein levels by immunohistochemistry. Collagen protein was measured using picrosirius red staining. In a separate group, rats were treated for 6 months with an ACE inhibitor. There were temporal and regional differences in the expression of TGF-β1, CTGF, and collagen after MI. Procollagen α1(I) mRNA expression increased in the border zone and scar peaking 1 week after MI, whereas collagen protein increased in all areas of the heart over the 180 days. Expression of TGF-β1 mRNA and protein showed major increases in the border zone and scar peaking 1 week after MI. The major increases in CTGF mRNA and protein occurred in the viable myocardium at 180 days after MI. Long-term ACE inhibition reduced left ventricular mass and decreased fibrosis in the viable myocardium, but had no effect on cardiac TGF-β1 or CTGF. TGF-β1 is involved in the initial, acute phase of inflammation and repair after MI, whereas CTGF is involved in the ongoing fibrosis of the heart. The antifibrotic benefits of captopril are not mediated through a reduction in CTGF.

Từ khóa


Tài liệu tham khảo

10.1038/ncb826

10.1016/j.yjmcc.2003.12.004

10.1016/S1359-6101(03)00044-3

10.1161/01.HYP.31.1.181

10.1111/j.1440-1681.1996.tb02782.x

10.1161/01.HYP.36.6.1105

10.1080/01971529008053267

10.1161/01.RES.0000065620.39919.20

10.1006/jmcc.2000.1215

10.1177/002215549904700507

10.1007/BF00227876

10.1016/S1071-9164(97)90007-5

10.1161/01.CIR.94.9.2285

10.1097/00004872-200018060-00013

10.1016/S0002-9440(10)63659-0

10.2337/diabetes.47.3.414

10.1074/jbc.M000976200

Hao JM, 2000, Am J Physiol, 279, H3020

10.1091/mbc.4.6.637

10.1179/his.1999.22.2.109

10.1385/0-89603-280-9:301

10.1177/002215549904700113

10.1006/mgme.2000.3032

10.1006/jmcc.1998.0799

10.1161/01.CIR.98.2.149

Passier RC, 1996, Am J Physiol, 271, H1040

10.1056/NEJM199209033271001

10.1161/01.CIR.72.2.406

10.1179/his.1999.22.1.9

10.1161/01.CIR.0000089129.51288.BA

10.1006/jmcc.1998.0721

10.3109/08977198809000251

10.1210/endo.142.5.8141

10.1006/jmcc.2001.1361

10.2337/diabetes.51.9.2709

10.1161/01.CIR.96.11.4065

10.1161/01.RES.62.4.757

10.1038/ki.1997.214

10.1053/ajkd.2001.27422

10.1007/s003950050149

10.1016/S0735-1097(01)01518-2

10.1161/01.CIR.98.23.2621

Yue P, 1998, Am J Physiol, 275, H250

Thông tin
Thông tin xuất bản

Journal of Histochemistry and Cytochemistry

Tập 53 Số 10

1245-1256

Thông tin tác giả